resTORbio announces initiation of study to evaluate if antiviral prophylaxis with RTB101 reduces the severity of COVID-19 in nursing home residents | resTORbio, inc

resTORbio, Inc.2020

Links

Leave a Reply

Your email address will not be published. Required fields are marked *